{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:38:36Z","timestamp":1788388716418,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41431-018-0116-4","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T17:28:23Z","timestamp":1526664503000},"page":"1339-1347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers"],"prefix":"10.1038","volume":"26","author":[{"given":"Berdine L","family":"Heesterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M H","family":"de Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andel GL","family":"van der Mey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora PM","family":"Corssmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3025-0882","authenticated-orcid":false,"given":"Frederik J","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit M","family":"Verbist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Paul G","family":"van Benthem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"116_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1399-0004.2011.01653.x","volume":"81","author":"EF Hensen","year":"2012","unstructured":"Hensen EF, van Duinen N, Jansen JC, et al. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clin Genet. 2012;81:284\u20138.","journal-title":"Clin Genet"},{"key":"116_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/gcc.1144","volume":"31","author":"PEM Taschner","year":"2001","unstructured":"Taschner PEM, Jansen JC, Baysal BE, et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosom Cancer. 2001;31:274\u201381.","journal-title":"Genes Chromosom Cancer"},{"key":"116_CR3","doi-asserted-by":"publisher","first-page":"er20141026","DOI":"10.1210\/er.2014-1026","volume":"35","author":"D Ta\u00efeb","year":"2014","unstructured":"Ta\u00efeb D, Kaliski A, Boedeker CC, et al. Current approaches and recent developments in the management of head and neck paragangliomas. Endocr Rev. 2014;35:er20141026.","journal-title":"Endocr Rev"},{"key":"116_CR4","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1038\/sj.onc.1207591","volume":"23","author":"EF Hensen","year":"2004","unstructured":"Hensen EF, Jordanova ES, van Minderhout IJHM, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene. 2004;23:4076\u201383.","journal-title":"Oncogene"},{"key":"116_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-014-0111-8","volume":"15","author":"JP Bayley","year":"2014","unstructured":"Bayley J-P, Oldenburg RA, Nuk J, et al. Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations. BMC Med Genet. 2014;15:111.","journal-title":"BMC Med Genet"},{"key":"116_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcdb.2015.05.011","volume":"43","author":"AS Hoekstra","year":"2015","unstructured":"Hoekstra AS, Devilee P, Bayley J-P. Models of parent-of-origin tumorigenesis in hereditary paraganglioma. Semin Cell Dev Biol. 2015;43:1\u20138.","journal-title":"Semin Cell Dev Biol."},{"key":"116_CR7","doi-asserted-by":"publisher","first-page":"ddw218","DOI":"10.1093\/hmg\/ddw218","volume":"25","author":"AS Hoekstra","year":"2016","unstructured":"Hoekstra AS, Addie RD, Ras C, et al. Parent-of-origin tumorigenesis is mediated by an essential imprinted modifier in SDHD -linked paragangliomas: SLC22A18 and CDKN1C are candidate tumor modifiers. Hum Mol Genet. 2016;25:ddw218.","journal-title":"Hum Mol Genet"},{"key":"116_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HPH Neumann","year":"2004","unstructured":"Neumann HPH, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292:943\u201351.","journal-title":"JAMA"},{"key":"116_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1677\/ERC-08-0284","volume":"16","author":"Timmers HJLM","year":"2009","unstructured":"HJLM Timmers, Gimenez-Roqueplo AP, Mannelli M, Pacak K. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2009;16:391\u2013400.","journal-title":"Endocr Relat Cancer"},{"key":"116_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1530\/ERC-11-0369","volume":"19","author":"V Piccini","year":"2012","unstructured":"Piccini V, Rapizzi E, Bacca A, et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer. 2012;19:149\u201355.","journal-title":"Endocr Relat Cancer"},{"key":"116_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E, et al. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat. 2010;31:41\u201351.","journal-title":"Hum Mutat"},{"key":"116_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/gim.2014.162","volume":"17","author":"L Evenepoel","year":"2015","unstructured":"Evenepoel L, Papathomas TG, Krol N, et al. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Genet Med. 2015;17:610\u201320.","journal-title":"Genet Med"},{"key":"116_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ejhg.2012.203","volume":"21","author":"BL Heesterman","year":"2013","unstructured":"Heesterman BL, Bayley JP, Tops CM, et al. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations. Eur J Hum Genet. 2013;21:469\u201370.","journal-title":"Eur J Hum Genet"},{"key":"116_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00259-015-3003-z","volume":"42","author":"C Lepoutre-Lussey","year":"2015","unstructured":"Lepoutre-Lussey C, Caramella C, Bidault F, et al. Screening in asymptomatic SDHx mutation carriers: added value of (18)F-FDG PET\/CT at initial diagnosis and 1-year follow-up. Eur J Nucl Med Mol Imaging. 2015;42:868\u201376.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"116_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.anorl.2013.05.003","volume":"131","author":"A Mediouni","year":"2014","unstructured":"Mediouni A, Ammari S, Wassef M, et al. Malignant head\/neck paragangliomas. Comparative Study. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:159\u201366.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"116_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ejvs.2013.01.018","volume":"45","author":"J Fruhmann","year":"2013","unstructured":"Fruhmann J, Geigl JB, Konstantiniuk P, Cohnert TU. Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. Eur J Vasc Endovasc Surg. 2013;45:431\u20136.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"116_CR17","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HPH Neumann","year":"2002","unstructured":"Neumann HPH, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459\u201366.","journal-title":"N Engl J Med"},{"key":"116_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1677\/ERC-09-0024","volume":"16","author":"B Havekes","year":"2009","unstructured":"Havekes B, van Der Klaauw AA, Weiss MM, et al. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas. Endocr Relat Cancer. 2009;16:527\u201336.","journal-title":"Endocr Relat Cancer"},{"key":"116_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/ejhg.2015.36","volume":"23","author":"LT Hulsteijn van","year":"2015","unstructured":"van Hulsteijn LT, Heesterman B, Jansen JC, et al. No evidence for increased mortality in SDHD variant carriers compared with the general population. Eur J Hum Genet. 2015;23:1713\u20136.","journal-title":"Eur J Hum Genet"},{"key":"116_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/cen.12223","volume":"79","author":"LT Hulsteijn van","year":"2013","unstructured":"van Hulsteijn LT, den Dulk AC, Hes FJ, Bayley JP, Jansen JC, Corssmit EPM. No difference in phenotype of the main Dutch SDHD founder mutations. Clin Endocrinol. 2013;79:824\u201331.","journal-title":"Clin Endocrinol"},{"key":"116_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ije\/dyu222","volume":"44","author":"LDAF Amorim","year":"2015","unstructured":"Amorim LDAF, Cai J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44:324\u201333.","journal-title":"Int J Epidemiol"},{"key":"116_CR22","unstructured":"Therneau TM. A package for survival analysis in S. version 2.38. 2015. \n                    https:\/\/CRAN.R-project.org\/package=survival"},{"key":"116_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ejhg.2009.112","volume":"18","author":"EF Hensen","year":"2010","unstructured":"Hensen EF, Jansen JC, Siemers MD, et al. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family. Eur J Hum Genet. 2010;18:62\u201366.","journal-title":"Eur J Hum Genet"},{"key":"116_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR25","doi-asserted-by":"publisher","first-page":"T91","DOI":"10.1530\/ERC-15-0268","volume":"22","author":"DE Benn","year":"2015","unstructured":"Benn DE, Robinson BG, Clifton-Bligh RJ. 15 Years of paraganglioma: clinical manifestations of paraganglioma syndromes types 1-5. Endocr Relat Cancer. 2015;22:T91\u2013103.","journal-title":"Endocr Relat Cancer"},{"key":"116_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jc.2011-2597","volume":"97","author":"F Schiavi","year":"2012","unstructured":"Schiavi F, Dematt\u00e8 S, Cecchini ME, et al. The endemic paraganglioma syndrome type 1: origin, spread, and clinical expression. J Clin Endocrinol Metab. 2012;97:637\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1055\/s-0037-1604347","volume":"78","author":"BL Heesterman","year":"2017","unstructured":"Heesterman BL, de Pont LMH, Verbist BM, et al. Age and tumor volume predict growth of carotid and vagal body paragangliomas. J Neurol Surg B Skull Base. 2017;78:497\u2013505. in press","journal-title":"J Neurol Surg B Skull Base"},{"key":"116_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","volume":"120","author":"RR Lonser","year":"2014","unstructured":"Lonser RR, Butman Ja, Huntoon K, et al. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120:1055\u201362.","journal-title":"J Neurosurg"},{"key":"116_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase. Cancer Cell. 2005;7:77\u201385.","journal-title":"Cancer Cell"},{"key":"116_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3171\/2013.10.JNS13659","volume":"120","author":"I Hussain","year":"2014","unstructured":"Hussain I, Husain Q, Baredes S, Eloy JA, Jyung RW, Liu JK. Molecular genetics of paragangliomas of the skull base and head and neck region: implications for medical and surgical management. J Neurosurg. 2014;120:321\u201330.","journal-title":"J Neurosurg"},{"key":"116_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2012.03.032","volume":"684","author":"Y Chen","year":"2012","unstructured":"Chen Y, Fu L, Han Y, et al. Testosterone replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing expression of cytokines HIF-1a, SDF-1a and VEGF. Eur J Pharmacol. 2012;684:116\u201324.","journal-title":"Eur J Pharmacol"},{"key":"116_CR32","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1210\/jc.2012-2975","volume":"98","author":"AP Gimenez-Roqueplo","year":"2013","unstructured":"Gimenez-Roqueplo AP, Caumont-Prim A, Houzard C, et al. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA investigators. J Clin Endocrinol Metab. 2013;98:4578\u201387.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nic.2015.12.005","volume":"26","author":"S Woolen","year":"2016","unstructured":"Woolen S, Gemmete JJ. Paragangliomas of the head and neck. Neuroimaging Clin N Am. 2016;26:259\u201378.","journal-title":"Neuroimaging Clin N Am"},{"key":"116_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1525-1497.2001.016004266.x","volume":"16","author":"AJ Barsky","year":"2001","unstructured":"Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16:266\u201375.","journal-title":"J Gen Intern Med"},{"key":"116_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0277-9536(96)00340-1","volume":"45","author":"CMT Gijsbers Van Wijk","year":"1997","unstructured":"Gijsbers Van Wijk CMT, Kolk AM. Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med. 1997;45:231\u201346.","journal-title":"Soc Sci Med"},{"key":"116_CR36","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/hed.22976","volume":"35","author":"C Su\u00e1rez","year":"2013","unstructured":"Su\u00e1rez C, Rodrigo JP, B\u00f6deker CC, et al. Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy. Head Neck. 2013;35:1195\u2013204.","journal-title":"Head Neck"},{"key":"116_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00405-013-2384-5","volume":"271","author":"C Su\u00e1rez","year":"2014","unstructured":"Su\u00e1rez C, Rodrigo JP, Mendenhall WM, et al. Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy. Eur Arch Otorhinolaryngol. 2014;271:23\u201334.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"116_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1210\/jc.2009-1632","volume":"95","author":"N Duinen van","year":"2010","unstructured":"van Duinen N, Steenvoorden D, Kema IP, et al. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab. 2010;95:209\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR39","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1210\/jc.2008-2504","volume":"94","author":"N Burnichon","year":"2009","unstructured":"Burnichon N, Rohmer V, Amar L, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94:2817\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"116_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.currproblcancer.2014.01.001.","volume":"38","author":"VL Martucci","year":"2014","unstructured":"Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer. 2014;38:7\u201341. \n                    https:\/\/doi.org\/10.1016\/j.currproblcancer.2014.01.001.","journal-title":"Curr Probl Cancer"},{"key":"116_CR41","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","volume":"43","author":"A Archier","year":"2016","unstructured":"Archier A, Varoquaux A, Garrigue P, et al. Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol Imaging. 2016;43:1248\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0116-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:42:08Z","timestamp":1684618928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0116-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0116-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]},"assertion":[{"value":"25 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}